Intravenous Autologous CD19 CAR-T Cells for R/R B-ALL

Clinical trial NCT03937544 · RECRUITING

Trial details

NCT number: NCT03937544
Sponsor: National University of Malaysia
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Relapsed B Acute Lymphoblastic Leukaemia Refractory B Acute Lymphoblastic Leukaemia

Start date: 2019-03-19
Primary completion: 2027-01-18
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.